Liberum
MENU

News /

Liberum acts as Nominated Adviser & Sole Bookrunner on the £29 million fundraise for Science in Sport plc

06 December 2018 |

SIS (1)

Liberum is pleased to announce that it acted as Financial Adviser, Nominated Adviser and Sole Bookrunner in relation to a placing & acquisition by Science in Sport plc, raising £29 million. The placing part funded the acquisition of PhD Nutrition Ltd for a total consideration of £32 million.

Science in Sport plc, a UK-headquartered market leading sports nutrition company that develops, manufactures and markets sports nutrition products for professional athletes and sports enthusiasts.

PhD is a UK-headquartered premium protein brand, which has developed into one of the UK's leading protein brands with a reputation for high quality and innovative products aimed at sports enthusiasts and gym lifestyle consumers.

The deal doubles the size of the Company and accelerates their ambition to become a global leader in premium performance nutrition. SIS and PhD are two businesses that have complementary brands, products, operations and sales channels which together create a well-balanced, cash generative company with enhanced potential.l.

Liberum Team 

Investment BankingClayton Bush, Clayton Bush, James Greenwood, William Hall, Stephanie Poulier

Sales – Oliver Baxendale, Julian Collett, Gerard O’Doherty, Sebastian Fernandez

Research – Wayne Brown, Tom Musson

Corporate Access – Marcio Remedios

Twitter@LiberumToday

LinkedInLiberum